A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer
Clinical trial NCT05690945 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05690945
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2029-06-01
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.